<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
<channel>
<title>Company News</title>
<link>https://www.investing.com</link>
<item>
<enclosure url="https://i-invdn-com.investing.com/news/world_news_2_108x81.jpg" length="10322" type="image/jpeg" />
<title>Accenture to acquire Brazil infrastructure firm Verum Partners</title>
<pubDate>2026-02-24 12:25:01</pubDate>
<author>Investing.com</author>
<link>https://www.investing.com/news/company-news/accenture-to-acquire-brazil-infrastructure-firm-verum-partners-93CH-4521144</link>
</item>
<item>
<enclosure url="https://i-invdn-com.investing.com/news/world_news_2_108x81.jpg" length="10322" type="image/jpeg" />
<title>Bitcoin treasury firm BSTR names Stefanowski as CFO</title>
<pubDate>2026-02-24 12:17:37</pubDate>
<author>Investing.com</author>
<link>https://www.investing.com/news/company-news/bitcoin-treasury-firm-bstr-names-stefanowski-as-cfo-93CH-4521116</link>
</item>
<item>
<enclosure url="https://i-invdn-com.investing.com/news/world_news_2_108x81.jpg" length="10322" type="image/jpeg" />
<title>Google, AES sign 20-year power deals for Texas data center</title>
<pubDate>2026-02-24 12:17:34</pubDate>
<author>Investing.com</author>
<link>https://www.investing.com/news/company-news/google-aes-sign-20year-power-deals-for-texas-data-center-93CH-4521115</link>
</item>
<item>
<enclosure url="https://i-invdn-com.investing.com/news/world_news_2_108x81.jpg" length="10322" type="image/jpeg" />
<title>Shoals Technologies partners with ON.energy for AI data centers</title>
<pubDate>2026-02-24 12:17:27</pubDate>
<author>Investing.com</author>
<link>https://www.investing.com/news/company-news/shoals-technologies-partners-with-onenergy-for-ai-data-centers-93CH-4521113</link>
</item>
<item>
<enclosure url="https://csv-storage.forexpros.com/slides/e479b8f50a4b62aa337edb2dd83cdf870071d42c91f356e9f2abe85abc90b458.png" length="245019" type="image/png" />
<title>ConvaTec 2025 slides: double-digit EPS growth, targets raised</title>
<pubDate>2026-02-24 12:16:56</pubDate>
<author>Investing.com</author>
<link>https://www.investing.com/news/company-news/convatec-2025-slides-doubledigit-eps-growth-targets-raised-93CH-4521110</link>
</item>
<item>
<enclosure url="https://i-invdn-com.investing.com/news/world_news_2_108x81.jpg" length="10322" type="image/jpeg" />
<title>First Watch CFO Mel Hope to retire later this year</title>
<pubDate>2026-02-24 12:09:27</pubDate>
<author>Investing.com</author>
<link>https://www.investing.com/news/company-news/first-watch-cfo-mel-hope-to-retire-later-this-year-93CH-4521074</link>
</item>
<item>
<enclosure url="https://i-invdn-com.investing.com/news/news_six_pile_108x81.jpg" length="8506" type="image/jpeg" />
<title>Aclaris starts phase 1b trial of ATI-052 in asthma patients</title>
<pubDate>2026-02-24 12:09:23</pubDate>
<author>Investing.com</author>
<link>https://www.investing.com/news/company-news/aclaris-starts-phase-1b-trial-of-ati052-in-asthma-patients-93CH-4521073</link>
</item>
<item>
<enclosure url="https://i-invdn-com.investing.com/news/world_news_2_108x81.jpg" length="10322" type="image/jpeg" />
<title>Diality names Peter Donato as chief financial officer</title>
<pubDate>2026-02-24 12:09:22</pubDate>
<author>Investing.com</author>
<link>https://www.investing.com/news/company-news/diality-names-peter-donato-as-chief-financial-officer-93CH-4521072</link>
</item>
<item>
<enclosure url="https://i-invdn-com.investing.com/news/world_news_2_108x81.jpg" length="10322" type="image/jpeg" />
<title>FDA grants breakthrough status to Larimar’s Friedreich’s ataxia drug</title>
<pubDate>2026-02-24 12:09:18</pubDate>
<author>Investing.com</author>
<link>https://www.investing.com/news/company-news/fda-grants-breakthrough-status-to-larimars-friedreichs-ataxia-drug-93CH-4521070</link>
</item>
<item>
<enclosure url="https://i-invdn-com.investing.com/news/world_news_2_108x81.jpg" length="10322" type="image/jpeg" />
<title>AC Immune begins phase 1 trial of brain-penetrant NLRP3 inhibitor</title>
<pubDate>2026-02-24 12:09:17</pubDate>
<author>Investing.com</author>
<link>https://www.investing.com/news/company-news/ac-immune-begins-phase-1-trial-of-brainpenetrant-nlrp3-inhibitor-93CH-4521069</link>
</item>
</channel>
</rss>
